NCT05883306View on ClinicalTrials.gov

Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

July 21, 2022

Study Completion Date

December 23, 2022

Conditions
Healthy SubjectsPharmacokinetics of 14C-labeled of LXI-15028
Interventions
DRUG

[14C]LXI-15028

\[14C\]LXI-15028

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

INDUSTRY